New Drug has Potential to Destroy Leukemia
White blood cells are the body's foot soldiers in its everyday battle against infections and diseases. Even when we are feeling well, they are working together in a carefully orchestrated manner to target and destroy dangerous substances in our body. Any disease that prevents the white blood cells from doing their job puts us at great risk for infection and illness. Leukemia is that kind of disease. It happens when our body's system for making white blood cells malfunctions, resulting in the uncontrolled production of abnormal white blood cells that cannot protect us against disease. If left untreated, leukemia can cause death in a matter of months. Simply put, leukemia is a cancer of the blood cells. It usually involves the white blood cells, but in rare cases involves the red blood cells and platelets as well. The disease originates in the bone marrow. Like all cancers, it is characterized by the uncontrolled growth of abnormal cells. When these defective cells accumulate in the bone marrow where they are produced, it inhibits the production of blood cells of every kind. All blood cells pass through many stages on their way to complete maturity, beginning within the bone marrow as immature cells called blasts. Leukemia can occur at any of these stages of development, affecting one of the two major categories of white blood cells: lymphoid cells or myeloid cells. According to J. Gordon McVie author of "Cancer Treatment: The Last 25 Years," states that each year, nearly 27,000 adults and more than 2,000 children in the United States learn that they have leukemia. It affects 13.2 per 100,000 men and 7.7 per 100,000 women in the United States. Chronic leukemia comprises 35% to 50%...
... middle of paper ...
...(1999): 323-331.
One-Hundred Percent Success for Leukemia Drug. BBC News Online 22 February 2000
*http://news.bbc.co.uk/hi/english/health/newsid-548000/548994.stm*.
Seppa, N. "New Drug Thwarts a Chronic Leukemia." Science News v156 i24 11
December 1999: 372.
Somer, Bradley. "STI-571 in The Treatment of CML: A Perspective on this New Agent,
and its Potential Future Utility." OncoLink. The University of Pennsylvania
Cancer Center. 15 February 2000
*http://oncolink.upenn.edu/disease/leukemia1/cml.html.*
Stephenson, Joan. "Researchers Buoyed by Promise of Targeted Leukemia Therapy."
Journal of American Medical Association v283 n3 19 January 2000: 317-
321.
Terwilleger, Michelle. "Pastor First to Benefit From New Cancer Drug." The
Bakersfield Californian 19 February 2000 *http://www.vbf.org/ron.htm*.
Thumbing through the pages of Business Week, the headline read Maybe Jaws Can Put the Bite on Cancer. Interested, I continued to read the short article. According to the reporter, Otis Port, researchers at California State University in Fresno say that they have isolated four substances in shark cartilage that appear to inhibit cancer (93). Curious, I continued to read the rest of the article. The chemicals block a mechanism discovered in the mid-1980s at Harvard University: Tumor cells secrete a protein called angiogenin that entices blood vessels to grow close to cancers and nourish them. The shark extracts counteract angiogenin and the tumor starves (93). I sat there pondering the concept and decided that I would further investigate this intoxicating find.
Cancer is a disease in which cells multiply out of control and gradually build a mass of tissue called a tumor. There has been a large amount of research dedicated to the treatment and cure of cancer. Several types of treatments have been developed. The following are just some of the major examples of cancer therapy: surgery, chemotherapy, radiation therapy, biologic therapy, biorhythms, unconventional treatments, and hyperthermia. Each type of treatment is discussed in detail below.
In 2013, the United States was said to have an estimated 1.6 million cancer patients. The majority of cancer patients turn to chemotherapy in hope to kill off all the spreading cancer cells so they can have a chance to live again. Chemotherapy is defined as the use of any drug to treat any disease, however people most commonly associate chemotherapy with drugs used to treat cancer. Although chemotherapy could be very effective, the rate of success solely depends on the type of cancer the patient has and could potentially be only one or two percent successful.
Leukemia and Lymphoma Society (LLS) is the worlds largest non-profit organization which funds blood cancer research and providing patient services and education. The LLS mission is to cure leukemia, lymphoma, Hodgkin's lymphoma and myeloma and to improve quality of patients and there families. This is done by discovering new cures and making blood cancers a story of the past.The organizations national office is located in White Plains, NY. Leukemia and Lymphoma Society has local chapters through out the United States and Canada.
The topic of this article is medication error related to chemotherapy drugs. Forty percent of medication errors have been related to chemotherapy drugs. It is imperative that the nurses are properly trained on these medications and fully understand what is being administered before giving it to the patient as well as know what the proper dose is before administering anything to the patient. More importantly the nurse must pay close attention to their patient’s response to the chemotherapy given to the patient or it could lead to a serious injury or death.
“The word 'leukemia' is a very frightening word. In many instances, it's a killer and it's something that you have to deal with in a very serious and determined way if you're going to beat it” - Kareem Abdul-Jabbar. Many people, including tons of children, fight leukemia every day trying to beat this vicious cancer. Without knowing how leukemia is exactly caused, it puts a damper on how to avoid it.
“When someone has cancer, the whole family and everyone who loves them does, too.” – Terri Clark
There are two types of lymphoma, Hodgkin disease and Non-Hodgkin lymphoma, and even though they are different they both begin the same way. Like other cancers, lymphoma results when cells divide too quickly or do not die because of a discrepancy in their genes. The cells that are affected in this type of cancer are white blood cells called lymphocytes. Lymphocytes make up around 20 to 40 percent of all white blood cells, and are divided into two categories, B or T. Both types help support the immune system by destroying infectious or foreign substances, but B lymphocytes make antibodies to fight these substances while T lymphocytes directly attack the unwanted substances. These cells work in the lymph system which is a part of the immune system. The main jobs of the lymph system are to protect the body from unwanted substances and to transport waste. The system includes many vital organs such as lymph nodes, spleen, bone marrow, thymus, and the digestive tract. When lymphocytes become cancerous they collect in the lymph nodes therefore blocking the passage of waste and other white blood cells while also using the nodes as a system to travel and spread to other parts of body. These cancerous cells do not die and become a burden for the body because they can no longer fulfill their ...
Chronic Lymphocytic Leukemia (CLL) is slow-progressing or “chronic”, cancer of the blood and bone marrow. CLL is the second most common leukemia in adults and one of the four primary types of leukemia. Certain risk factors have been identified including age, race, sex, family history of blood and bone marrow cancers and chemical exposure. Most people diagnosed with CLL are white males over the age of 60. Occurrence increases with age and a marked increase after 60. Herbicides, insecticides and Agent Orange used in the Vietnam War have shown to increase the risk of developing CLL. There are approximately 15,000 new cases diagnosed each year.
Leukemia is a cancer of the white blood cells. It begins in the bone marrow, the soft tissue inside the bones. Within the bone marrow is where white blood cells are created, that help fight off bacteria, viruses, and other microorganisms within the body that cause infections. The disease develops to when the white blood cells are being produced out of control. The cells that are being produced do not work properly as they should, they grow faster than a normal cell would and don’t know when to stop growing. Overtime, if not treated properly, the white blood cells will over crowd blood cells, creating a serious problem such as anemia, bleeding and infection. Leukemia cells can spread to the lymph nodes and other organs in the body causing swelling and pain.
The emphasis on health and fitness has become paramount in our society today in an effort to prevent and combat diseases such as Cancers. Cancers are a group of over 100 diseases that affects every aspect of the human system from skin, to bones, to muscles, to blood. One of the most common blood disorders is Leukemia. As defined by the U.S. National Library of Medicine, Leukemia is a type of blood cancer that begins in the bone marrow. The bone marrow is the soft tissue in the center of the bone that is responsible for the production of blood cells. The term leukemia means white blood. The term leukocytes refer to white blood cells, which are body’s defense against infections and other foreign substances. When Leukemia occurs there is an uncontrolled increase in the number of white blood cells. When this occurs, these cancerous cells inhibit the production of healthy red blood cells, platelets, and mature white blood cells. Over time the cancerous cells can spread to the bloodstream and lymph nodes. They can also travel to the Central Nervous System and the rest of the body.
Chronic Myeloid leukemia (CML) is a blood and bone marrow disease that slowly progresses. The disease usually occurs in middle aged or older individuals and rarely occurs in children. In CML, an unusually high number of blood stem cells become granulocytes. These granulocytes, also called leukemia cells are irregular in shape and do not develop into healthy white blood cells. Eventually, they concentrate in the blood leaving no room for healthy cells which may lead to infection, anemia, or bleeding. The typical signs of CML include fatigue, fever, night sweats, and weight loss (6).
The East Pennsboro elementary school raised money for a statue at a local park. The statue was a ring of children that were holding hands. There was one child missing; the link was broken. The statue was dedicated to East Pennsboro students that did not make it to their graduation. My sophomore year of high school inspired this piece of artwork.
For years people have been looking for a cure for the devastating disease of cancer. Cancer is the third highest killer in the US with over 2,500,000 victims per year. Oncologists and scientists around the country are researching all forms of cancer in an effort to understand, treat, and ultimately defeat this disease. Already there have been numerous advances in the field, such as chemotherapy and gene therapy. One advance has been the use of a cell process known as apoptosis. By harnessing this normal cell process, scientists hope to have found an effective way to combat cancer.
As noted in a review of the retrieved articles, different types of medications were used as treatment for leukemia. Many research studies were conducted in order to find a way to limit the progression of leukemia. Leukemia is a rapid replication of atypical white blood cells (WBCs) that reduces the ability of WBCs to fight the infection (American Society of Hematology). Leukemia is classified into types: myeloid and lymphoid leukemia. Myeloid /lymphoid leukemia has acute and chronic phases. Acute myeloid leukemia (AML) is an increase of myoblasts in peripheral blood or bone marrow (Kantarjian et al., 2010). This study used a comparison method to check the effect of intensive chemotherapy in older patients with AML (Kantarjian et al., 2010). Chemotherapy is a standard treatment for leukemia (Buizer et al., 2009). Older Patients with AML were excluded from the AML therapy trial (Kantarjian et al., 2010). Recently, researchers have focused on the older population with AML who received intensive chemotherapy many years ago (Kantarjian et al., 2010). Patients 65-69 years old and patients with Myelodysplastic syndrome (MDS) were included in this study (Kantarjian et al., 2010). χ2 test was involved in this research to compare between the variables (Kantarjian et al., 2010). Age was tested as continuous variables (Kantarjian et al., 2010). In addition, mortality rate...